Prepare for the CRA exam by learning retinal angiography as a chain of decisions rather than a list of terms: identify the fluorescence mechanism, confirm it with phase timing, separate fluorescein from indocyanine green logic, rule out acquisition artifacts, and rehearse adverse-event responses. Work through two written scenarios, then grade yourself with a rubric that asks for mechanism, evidence, and modality in every answer. Confirm administrative details such as eligibility and scheduling directly with the Ophthalmic Photographers' Society.
Classify the mechanism before naming any fluorescence finding
Hyperfluorescence and hypofluorescence are not single findings; each has several distinct mechanisms. Leak, pool, stain, transmit, block, or autofluoresce — decide which mechanism produced the appearance before attaching a diagnostic label.
Hyperfluorescence mechanisms differ in how they interact with dye. Leakage is dye escaping through incompetent vascular or retinal pigment epithelium barriers, growing in area and intensity through late frames. Pooling fills an anatomical space such as a serous detachment. Staining accumulates slowly in tissue like drusen or a scar without expanding beyond its borders. A transmission, or window, defect appears when damaged RPE lets normal choroidal fluorescence show through early and hold steady. Pre-existing autofluorescence brightens before dye arrives.
Hypofluorescence has its own fork: a blocking defect is something in front of the fluorescence — blood, pigment, lipid — that masks it, while vascular filling failure means the dye simply never arrives. The practical test is to compare early frames with late frames. Blocking usually persists unchanged; a window defect is present early and stable; leakage enlarges. Build a one-page sheet listing each mechanism, its early-frame appearance, and its late-frame behavior, and require yourself to cite that behavior whenever you name a finding.
Use angiogram phases to constrain what each frame can tell you
The angiogram unfolds in a recognizable sequence — choroidal and arterial filling, arteriovenous transit, venous phases, recirculation, and late frames. Each phase can confirm or exclude certain mechanisms, so read findings against the phase clock.
Early frames after injection show choroidal flush and arterial filling; a hypofluorescent area here may indicate a blocking defect or delayed filling, but leakage is essentially impossible this soon because dye has not had time to escape barriers. During the arteriovenous phase, dye transits capillaries and laminar venous filling begins along vessel walls. Venous and recirculation frames show complete venous filling and decreasing overall intensity. Late frames, minutes after injection, are where staining, pooling, and leakage declare themselves.
Train yourself to ask two questions per finding: what phase is this frame in, and could this mechanism physically exist at that time? A bright spot present in the first arterial frames and unchanged in late frames points toward a transmission defect or autofluorescence, not active leakage. Conversely, a lesion that looks unremarkable early and blooms late is behaving like leakage, pooling, or staining — and its borders tell you which. Practice by writing the phase name in the margin of every frame you review, then write the mechanism that phase permits.
FAG versus ICGA: different dyes, different physics, different questions
Fluorescein and indocyanine green differ in binding behavior, fluorescence spectrum, and barrier leakage, which is why fluorescein best reveals retinal vascular dynamics while ICG best reveals choroidal circulation.
Sodium fluorescein is a small molecule that is largely protein-bound in plasma — roughly three quarters or more — and it is the minority unbound fraction that fluoresces and leaks through fenestrated choriocapillaris and barrier defects. It absorbs blue light and emits green-yellow. Because choroidal fluorescence is largely obscured by RPE pigment and by dye escaping the choriocapillaris, fluorescein angiography excels at retinal vascular detail, barrier integrity, and macular leakage. ICG is larger and even more strongly protein-bound, escapes the choriocapillaris much more slowly, and fluoresces in the near-infrared, which penetrates RPE and thin blood far better.
The exam-relevant skill is choosing the modality logic that matches the question being asked. If the question concerns retinal capillary detail, microaneurysms, or macular edema, fluorescein physics answers it. If it concerns choroidal vessels beneath pigment or hemorrhage, near-infrared ICG imaging has the advantage. Also carry the safety contrast: ICG formulations contain iodine, so iodine allergy history matters differently than for fluorescein. Use the comparison table below as a study spine, then test yourself by re-explaining each row in your own words.
| Property | Fluorescein angiography | ICG angiography |
|---|---|---|
| Molecule size and binding | Small; largely protein-bound, with the unbound fraction leaking through fenestrations and barrier defects | Large; even more strongly protein-bound; stays intravascular longer |
| Fluorescence spectrum | Absorbs blue, emits green-yellow | Near-infrared absorption and emission |
| Penetration through pigment and blood | Limited; RPE and hemorrhage obscure signal | Better; infrared penetrates pigment and thin blood |
| Circulation best shown | Retinal vasculature and barrier integrity | Choroidal circulation |
| Typical late-frame behavior | Leakage, pooling, and staining are prominent | Vessel definition persists; less rapid extrusion |
| Allergy consideration | Distinct fluorescein reaction history | Iodine content requires iodine allergy check |
Catch acquisition problems mid-run instead of discovering them at the desk
Focus error, misalignment, uneven flash, eyelash shadows, and media opacity can mimic or mask pathology. Review frames within each run so a correctable problem is fixed while the patient is still seated.
Technique errors have recognizable signatures. Poor focus softens capillary detail symmetrically around the fovea; misalignment or small pupils vignette one side of the field; a degrading flash tube or incorrect flash setting produces uniformly dim frames; lashes and lids cast dense linear shadows; cataract and vitreous haze scatter light and wash contrast. None of these are disease, and confusing them with retinal findings is the classic interpretation mistake that a disciplined review sequence prevents.
Adopt a mid-run check habit: after the transit frames, pause and grade image quality — centration, focus on the chosen landmark, flash consistency, and any fixed shadow that does not move with the eye. If quality is failing, correct alignment or focus and reacquire during the same session while dye is still circulating, rather than accepting a degraded late phase. During study, deliberately collect examples of each artifact from teaching atlases and write one sentence describing how you would distinguish it from the pathology it resembles.
Worked scenario: separating a window defect from leakage
In a late-phase frame showing a bright mid-peripheral spot, the tempting label is leakage. Comparing early frames reveals the spot was equally bright from the start — a transmission defect, which changes the description entirely.
Scenario: an angiogram run of a macula shows a hyperfluorescent spot near the arcades that appears bright in late frames with fairly crisp borders. The plausible mistake is to call it leakage and describe an expanding focus of vascular abnormality. The better decision is to pull the early arterial frames: the spot is already hyperfluorescent there, with the same size and intensity, and choroidal fluorescence beneath it appears increased. That early-and-stable pattern is the signature of an RPE transmission (window) defect.
Why it matters: the two mechanisms describe different anatomy and different disease behavior. Leakage implies barrier breakdown and active dye escape that enlarges over time; a window defect is a passive see-through of normal choroidal fluorescence through compromised RPE, stable across the run. A report built on the wrong mechanism misdirects the reader about progression risk. Make this a habit: for any hyperfluorescent finding, write its early-frame brightness, its late-frame brightness, and whether its borders expanded. If you cannot supply all three, your label is a guess, not a classification.
Safety decisions during injection and imaging: rehearse the fork points
Angiography safety rests on recognizing when a patient reaction is mild versus systemic, stopping imaging, and following the clinic's emergency protocol. Rehearse the decision fork in words before you ever face it.
Mild, common reactions to fluorescein include transient nausea and yellowish discoloration of skin and urine; extravasation at the injection site causes local pain and requires prompt attention to prevent tissue injury. The reactions that demand immediate escalation are systemic hypersensitivity signs: hives, itching beyond the injection site, respiratory symptoms, or circulatory collapse. The clinical skill is matching observation to response level — continue imaging for a brief nausea mention? No. Stop, assess the patient, document, and let the supervising clinician direct care.
Scenario: two minutes after injection a patient says they feel itchy and you notice flushing. The plausible mistake is to assume simple nervousness, keep shooting frames, and mention it afterward. The better decision is to stop imaging immediately, stay with the patient, evaluate for spreading urticaria, wheeze, or light-headedness, notify the supervising clinician, and document time, symptoms, and actions. Why it matters: hypersensitivity can progress, and the first minutes determine how well it is managed. In study sessions, write out your clinic's response fork from memory — mild reaction, extravasation, systemic reaction — and check it against your written protocol.
A graded practice exercise, self-check rubric, and preparation sequence
Work through de-identified or published teaching angiograms with a three-part classification habit, grade yourself against the rubric below, then follow a staged sequence from mechanisms to full-run synthesis and readiness checks.
Exercise: assemble ten teaching angiogram runs from an atlas or your own de-identified cases. For each run, write three sentences — the mechanism of the key finding, the phase evidence that supports it, and whether fluorescein or ICG physics answers the clinical question. Score one point per element. A score of 24/30 or better before your final two weeks of study is a useful learning milestone, not a prediction of any exam result; a lower score tells you to repeat the mechanism sheet drill, not to panic.
Preparation sequence: weeks one and two, master the fluorescence mechanisms and rebuild your one-page sheet from memory; week three, drill phases by annotating frame series with phase names and permitted mechanisms; week four, study the FAG–ICG comparison until you can re-derive each table row; week five, run artifact-spotting on low-quality images plus written safety-fork rehearsal; week six, synthesize with full-run classifications under time pressure. Readiness checks: you can explain why a blocking defect looks the same early and late, re-derive the FAG–ICG table without notes, name three acquisition artifacts and their signatures, and recite your clinic's adverse-event fork. One short administrative note: for eligibility, scheduling, and current content outlines, rely on the Ophthalmic Photographers' Society at the link below.
References and further reading
Use these references to explore the concepts and check the latest information from the relevant organizations.